Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data

Structure's pill is part of the same class of drugs as Novo Nordisk's blockbuster diabetes drug Ozempic and weight loss counterpart Wegovy.

from Health and Science https://ift.tt/NixJOrI
https://ift.tt/UsBcmgF
https://ift.tt/ZM2itxu